Table 3.
Association between rs73064425 with age and comorbidities included in CCI
| Outcome | OR* | 95%CI | P Value* |
|---|---|---|---|
| Age | 0.98 | 0.71–1.35 | 0.90 |
| Myocardial infarction (MI, %) | 0.98 | 0.79–1.22 | 0.86 |
| Congestive heart-failure (CHF, %) | 1.11 | 0.82–1.50 | 0.48 |
| Peripheral vascular disease (PVD, %) | 1.12 | 0.87–1.45 | 0.38 |
| Cerebrovascular disease (CVD, %) | 0.75 | 0.58–0.97 | 0.03 |
| Dementia (%) | 1.09 | 0.68–1.78 | 0.71 |
| Chronic pulmonary disease (CPD, %) | 1.06 | 0.93–1.20 | 0.36 |
| Rheumatic diseases (Rh, %) | 0.97 | 0.72–1.31 | 0.86 |
| Peptic ulcer disease (PUD, %) | 0.90 | 0.68–1.19 | 0.47 |
| Mild liver disease (MLD, %) | 0.90 | 0.66–1.24 | 0.53 |
| Diabetes (DM, %) | 0.91 | 0.77–1.08 | 0.29 |
| Hemiplegia / Paraplegia | 1.12 | 0.72–1.73 | 0.61 |
| Moderate or severe renal disease (SRD, %) | 1.16 | 0.88–1.52 | 0.30 |
| Diabetes with end-organ damage (DMD, %) | 0.81 | 0.46–1.41 | 0.45 |
| Any malignant tumor (MT, %) | 0.95 | 0.82–1.11 | 0.54 |
| Moderate or severe liver disease (SLD, %) | 1.29 | 0.62–2.67 | 0.49 |
| Metastatic solid tumor (ST, %) | 0.95 | 0.64–1.41 | 0.79 |
| AIDS/HIV | 2.15 | 0.63–7.31 | 0.22 |
*Odds ratio and P value were estimated in the logistic regression model, adjusted for age, gender, income, BMI, and genotype batch